This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
J

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs. Placebo in Stage IB-IIIA RET+ NSCLC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jonathan Goldman
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jonathan Goldman
159 views
June 14, 2024

Chapters

Introduction to RET & Selpercatinib

00:00

LIBRETTO-001 Trial & Results

01:59

Adverse Events & Management

04:03

Phase III Trial & Efficacy

06:02

LIBRETTO-432 Trial Design & Goals

07:55

Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

2024 ASCO® Annual Meeting Insights Hub: Lung Videos

17:22

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO …

2024 ASCO® Annual Meeting Insights Hub

A. Chiang

406 views

·

4 months ago
40:00

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

ecancer

B. Gyawali

97 views

·

4 months ago
04:26

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consol…

ecancer

P. Iyengar

37 views

·

4 months ago
View All

Recommended

17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.3K views

·

8 months ago
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

810 views

·

4 months ago
18:47

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

6.4K views

·

2 years ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

7 months ago
11:07

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

2.3K views

·

1 year ago
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

909 views

·

8 months ago
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

499 views

·

4 months ago
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

468 views

·

5 months ago
13:19

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

E. Rodriguez

2.1K views

·

1 year ago
14:17

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Ther…

Insights from 2024 WCLC

J. Von Der Thusen

179 views

·

4 weeks ago
09:40

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

John Conibear

1.9K views

·

1 year ago
07:31

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Imp…

Insights from 2023 ASCO® Annual Meeting

J. West

963 views

·

1 year ago
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

533 views

·

4 months ago
10:17

New

Treatment Updates in Early Stage NSCLC - Advances in Thoracic Oncolo…

Total Health

J. Porter

148 views

·

3 weeks ago
14:22

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

115 views

·

2 months ago
08:18

ADC in Combination With Immunotherapy for NSCLC

MI&T Congressi

S. Liu

211 views

·

3 months ago
22:08

How the Experts Treat: Early Stage NSCLC With Curative Intent

Integrity CE

S. Liu

144 views

·

3 months ago
20:27

Progress in the Treatment of NSCLC

Yale Cancer Center

R. Herbst

508 views

·

11 months ago
11:40

New Immune Checkpoint Inhibitors in Lung Cancer

MI&T Congressi

S. Peters

198 views

·

3 months ago
10:00

WCLC 2024 Summary: Comparing Treatment for Locally Advanced NSCLC - …

Insights from 2024 WCLC

J. Donington

146 views

·

1 month ago
AUTOPLAY